SNT-5505 phase 2a myelofibrosis combination study (add on to...

  1. 13 Posts.
    lightbulb Created with Sketch. 4
    SNT-5505 phase 2a
    myelofibrosis
    combination study
    (add on to JAK
    inhibitor)
    with interim data with 6 months treatment due first week dec 24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.3¢
Change
0.000(0.00%)
Mkt cap ! $102.4M
Open High Low Value Volume
6.3¢ 6.3¢ 6.3¢ $12.08K 191.8K

Buyers (Bids)

No. Vol. Price($)
1 226979 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 429345 2
View Market Depth
Last trade - 10.03am 31/07/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.